A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
Clinical trial NCT02821754 · COMPLETED
Trial details
- NCT number
- NCT02821754
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-05
- Primary completion
- 2021-02-17
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.